Assembly Biosciences (ASMB) Shares Outstanding (2010 - 2026)

Assembly Biosciences' Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $11.2 million for Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 86.71% year-over-year to $11.2 million in Q4 2025; TTM through Dec 2025 was $11.2 million, a 86.71% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 86.71% from the prior year.
• Shares Outstanding (Entity) declined to $11.2 million in Q4 2025 per ASMB's latest filing, from $12.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $12.7 million in Q3 2025 and bottomed at $3.3 million in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $4.4 million (2023), against an average of $5.7 million.
• Across the five-year window, Shares Outstanding (Entity) climbed 1.61% in 2022 and surged 99.64% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $4.0 million in 2021, then increased by 1.61% to $4.1 million in 2022, then soared by 34.57% to $5.5 million in 2023, then grew by 9.52% to $6.0 million in 2024, then soared by 86.71% to $11.2 million in 2025.
• Per Business Quant, the three latest ASMB Shares Outstanding (Entity) figures stand at $11.2 million (Q4 2025), $12.7 million (Q3 2025), and $7.7 million (Q2 2025).